Newsgroups Main » Newsgroups Directory » Science and Technology » Medicine

Hepatitis ( sci.med.diseases.hepatitis )
spacer NewsDemon Usenet 2021 Access
 
From [email protected] Wed Jun 21 01:16:04 1995 Status: RO Path: uunet!bounce-back From: [email protected] (Abdul W Abdul) Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.telemedicine,sci.med.pathology,talk.politics.medicine Subject: RFD: sci.med.diseases.hepatitis Followup-To: news.groups Date: 21 Jun 1995 01:11:27 -0400 Organization: Leeds University, School of Medicine Lines: 108 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> NNTP-Posting-Host: rodan.uu.net Xref: gs2.UU.NET news.announce.newgroups:7068 news.groups:154640 bionet.virology:3598 sci.med:132684 sci.med.diseases.cancer:2982 sci.med.telemedicine:6043 sci.med.pathology:827 talk.politics.medicine:27528                      REQUEST FOR DISSCUSSION (RFD)            unmoderated newsgroup sci.med.diseases.hepatitis  Newsgroups line: sci.med.diseases.hepatitis  Hepatitis diseases.  This is a formal Request for Discussion on the creation of the unmoderated newsgroup sci.med.diseases.hepatitis.  It is being issued according to the accepted guidelines for newsgroup creation.  Its language is based on previous RFDs.   RATIONALE ==========  Hepatitis disease meaning the inflammation of the liver (hepat=liver, itis=inflammation) is a serious disease usually caused by hepatitis virus with millions of people infected throughout the world. The discussion of hepatitis diseases appears regularly in other related newsgroups such as sci.med, sci.med.diseases.cancer and bionet.virology, with demands for more information on the disease or even requests for help on particular issues concerning hepatitis. There is a mailing list for hepatitis C patients, and it is increasing daily in size.  The mailing list members (more than 150) are interested in such newsgroup, because it will be their gateway to the world for getting more support and information.  I also found many supporters for the creation of this newsgroup, when I had posted a pre-RFD enquiry to bionet.virology.   CHARTER ========  The proposed newsgroup would be devoted to all aspects and kinds of hepatitis diseases.  This newsgroup would be a good place where all people who are interested in the disease (doctors and experts in this field) can communicate with each other and share views and opinions. Not forgetting millions of people who are infected with hepatitis, this newsgroup would give support to those people and would be a good place for them to interact with the experts.  Let me make it clear here that the creation of this newsgroup is not intended to fractionate or separate hepatitis discussion in any other related newsgroup, but is to create a new specialised discussion forum on hepatitis diseases.  So, articles regarding hepatitis cross-posted to other related newsgroups are welcomed.  A partial list of the intended topics would be:  -All types of viral hepatitis and non viral hepatitis. -Prognosis and symptoms of hepatitis. -Complications of hepatitis. -The chronic carrier state. -Vaccination and drugs. -Epidemiology of hepatitis. -Books, journals, articles and newsletters related to hepatitis. -Support for hepatitis patients.  MAILING LISTS ==============  There is a mailing list for Hepatitis C patients. The mailing list owner is Geffrey Thorpe ([email protected]). To subscribe to this mailing list send a message to:  [email protected]  and write in the body of the message: SUB HEPV-L yourfirstname yourlastname Example: SUB HEPV-L John Smith  There is a plan to establish a gateway between the mailing list and the newsgroup.   DISTRIBUTION ============  This RFD is being cross-posted to the following relevant newsgroups :  news.announce.newgroups, news.groups, bionet.virology, sci.med, sci.med.diseases.cancer, sci.med.telemedicine, sci.med.pathology, talk.politics.medicine.  In addition, it will be posted to the following mailing list :  [email protected]   PROCEDURE ==========  Please post any responses to this message to "news.groups" newsgroup only.  All discussion about the merits of this proposal should appear on news.groups.  FUTURE CALL FOR VOTES (CFV) ============================  After a discussion period of 21-30 days, if there are no overwhelming objections to the proposed newsgroup there will be a Call For Votes (CFV) posted to the same newsgroups as this RFD.  The voting period will be at least 21 days.  If the newsgroup passes by receiving 100 more YES votes than NO votes, and at least twice as many YES votes as NO votes, it will be created.  Proponent: [email protected] (Abdul W Abdul) Mentor: [email protected] (Taneli Huuskonen)  From [email protected] Mon Jul 24 18:09:03 1995 Path: uunet!in1.uu.net!bounce-back From: [email protected] (Warren Lavallee) Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.pathology,sci.med.telemedicine,talk.politics.medicine Subject: CFV: sci.med.diseases.hepatitis Followup-To: poster Date: 20 Jul 1995 22:22:06 -0000 Organization: Usenet Volunteer Votetakers Lines: 119 Sender: [email protected] Approved: [email protected] Expires: 11 Aug 1995 00:00:00 GMT Message-ID: <[email protected]> Reply-To: [email protected] NNTP-Posting-Host: rodan.uu.net Xref: uunet news.announce.newgroups:7191 news.groups:160293 bionet.virology:3910 sci.med:136237 sci.med.diseases.cancer:3442 sci.med.pathology:1027 sci.med.telemedicine:6406 talk.politics.medicine:30451                            FIRST CALL FOR VOTES (of 2)                  unmoderated group sci.med.diseases.hepatitis  Newsgroups line: sci.med.diseases.hepatitis	Hepatitis diseases.  Votes must be received by 23:59:59 UTC, 10 Aug 1995.  This vote is being conducted by a neutral third party.  For voting questions only contact Warren Lavallee <[email protected]>.  For questions about the proposed group contact Abdul W Abdul <[email protected]>.  RATIONALE  Hepatitis disease meaning the inflammation of the liver (hepat=liver, itis=inflammation) is a serious caused usually by hepatitis virus with millions of people infected throughout the world. The discussion of hepatitis diseases appears regularly in other related newsgroups such as sci.med, sci.med.diseases.cancer and bionet.virology, with demands for more information on the disease or even requests for help on particular issues conerning hepatitis. There is a mailing list for hepatitis C patients, and it is increasing daily in size. The mailing list members (more than 150) are interested in such newsgroup, because it will be there gateway to the world for getting more support and information.  I also found many supporters for the creation of this newsgroup, when I had posted a pre-RFD enquiry to bionet.virology.  CHARTER  The proposed newsgroup would be devoted to all aspects and kinds of hepatitis diseases. This newsgroup would be a good place where all people interested in the disease (doctors and experts in this field) can communicate with each other and share views and opinions. Not forgetting millions of people who are infected with hepatitis, this newsgroup would give support to those people and would be a good place for them to interact with the experts. Let me make it clear here that the creation of this newsgroup is not intended to fractionate or separate hepatitis discussion in any other related newsgroup, but is to create a new specialized discussion forum on hepatitis diseases. So, articles regarding hepatitis cross-posted to other related newsgroups are welcomed.  A partial list of the intended topics would be:  	-All types of viral hepatitis and non viral hepatitis. 	-Prognosis and symptoms of hepatitis. 	-Complications of hepatitis. 	-The chronic carrier state. 	-Vaccines and drugs. 	-Epidemiology of hepatitis. 	-Books, journals, articles and newsletters related to hepatitis. 	-Support for hepatitis patients.  There is a plan to establish a gateway between HEPV-L mailing list and the newsgroup.  HOW TO VOTE  Send MAIL to:   [email protected] Just Replying should work if you are not reading this on a mailing list.  Your mail message should contain *one* and only one of the following statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.       I vote YES on sci.med.diseases.hepatitis       I vote NO on sci.med.diseases.hepatitis       I vote ABSTAIN on sci.med.diseases.hepatitis       I CANCEL my vote on sci.med.diseases.hepatitis  Neither ABSTAIN nor CANCEL messages are counted as votes; they serve only to cancel any previous vote. Abstentions are noted in the final vote list, whereas CANCEL removes your vote from that list entirely. (This is the only difference between the two.)  Anything else may be rejected by the automatic vote counting program.  The votetaker will respond to your received ballots with a personal acknowledge- ment by mail - if you do not receive one within several days, try again. It's your responsibility to make sure your vote is registered correctly.  If you later change your mind you may vote again; only your last valid vote will count.  Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI forms are considered anonymous votes. (The vote must be mailed directly from the voter to the votetaker.)  In cases where voting fraud is determined to have occurred, it is standard operating procedure to delete ALL votes submitted by the violator.  If you give anyone a copy of the CFV, it must be whole and unmodified. When in doubt, ask the votetaker.  Standard Guidelines for voting apply: no more than one vote per person, no more than one vote per account. If you attempt multiple votes or other vote fraud, all your votes may be canceled and your name published.  The complete vote list will be posted with the vote result, including how each person voted. Note that Usenet votes are not done by secret ballot.  There will then be a five-day period during which the published vote list may be corrected and any irregularities addressed. The requirements for group creation are 100 more YES votes than NO votes, and 2/3 of all counted votes being YES.  DISTRBUTION This CFV has been cross posted to: 	bionet.virology 	sci.med 	sci.med.diseaes.cancer 	sci.med.pathology 	sci.med.telemedicine 	talk.politics.medicine  And EMailed to: 	HEPV-L mailing list ([email protected])  From [email protected] Mon Jul 31 13:47:39 1995 Path: uunet!bounce-back From: [email protected] (Warren Lavallee) Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.pathology,sci.med.telemedicine,talk.politics.medicine Subject: 2nd CFV: sci.med.diseases.hepatitis Followup-To: poster Date: 31 Jul 1995 17:46:50 -0000 Organization: Usenet Volunteer Votetakers Lines: 119 Sender: [email protected] Approved: [email protected] Expires: 11 Aug 1995 00:00:00 GMT Message-ID: <[email protected]> Reply-To: [email protected] NNTP-Posting-Host: rodan.uu.net Archive-Name: sci.med.diseases.hepatitis Xref: uunet news.announce.newgroups:7253 news.groups:162085 bionet.virology:4032 sci.med:137430 sci.med.diseases.cancer:3607 sci.med.pathology:1078 sci.med.telemedicine:6503 talk.politics.medicine:30939                            LAST CALL FOR VOTES (of 2)                  unmoderated group sci.med.diseases.hepatitis  Newsgroups line: sci.med.diseases.hepatitis	Hepatitis diseases.  Votes must be received by 23:59:59 UTC, 10 Aug 1995.  This vote is being conducted by a neutral third party.  For voting questions only contact Warren Lavallee <[email protected]>.  For questions about the proposed group contact Abdul W Abdul <[email protected]>.  RATIONALE  Hepatitis disease meaning the inflammation of the liver (hepat=liver, itis=inflammation) is a serious caused usually by hepatitis virus with millions of people infected throughout the world. The discussion of hepatitis diseases appears regularly in other related newsgroups such as sci.med, sci.med.diseases.cancer and bionet.virology, with demands for more information on the disease or even requests for help on particular issues conerning hepatitis. There is a mailing list for hepatitis C patients, and it is increasing daily in size. The mailing list members (more than 150) are interested in such newsgroup, because it will be there gateway to the world for getting more support and information.  I also found many supporters for the creation of this newsgroup, when I had posted a pre-RFD enquiry to bionet.virology.  CHARTER  The proposed newsgroup would be devoted to all aspects and kinds of hepatitis diseases. This newsgroup would be a good place where all people interested in the disease (doctors and experts in this field) can communicate with each other and share views and opinions. Not forgetting millions of people who are infected with hepatitis, this newsgroup would give support to those people and would be a good place for them to interact with the experts. Let me make it clear here that the creation of this newsgroup is not intended to fractionate or separate hepatitis discussion in any other related newsgroup, but is to create a new specialized discussion forum on hepatitis diseases. So, articles regarding hepatitis cross-posted to other related newsgroups are welcomed.  A partial list of the intended topics would be:  	-All types of viral hepatitis and non viral hepatitis. 	-Prognosis and symptoms of hepatitis. 	-Complications of hepatitis. 	-The chronic carrier state. 	-Vaccines and drugs. 	-Epidemiology of hepatitis. 	-Books, journals, articles and newsletters related to hepatitis. 	-Support for hepatitis patients.  There is a plan to establish a gateway between HEPV-L mailing list and the newsgroup.  HOW TO VOTE  Send MAIL to:   [email protected] Just Replying should work if you are not reading this on a mailing list.  Your mail message should contain *one* and only one of the following statements.  DO NOT QUOTE THIS CFV IN YOUR VOTE.       I vote YES on sci.med.diseases.hepatitis       I vote NO on sci.med.diseases.hepatitis       I vote ABSTAIN on sci.med.diseases.hepatitis       I CANCEL my vote on sci.med.diseases.hepatitis  Neither ABSTAIN nor CANCEL messages are counted as votes; they serve only to cancel any previous vote. Abstentions are noted in the final vote list, whereas CANCEL removes your vote from that list entirely. (This is the only difference between the two.)  Anything else may be rejected by the automatic vote counting program.  The votetaker will respond to your received ballots with a personal acknowledge- ment by mail - if you do not receive one within several days, try again. It's your responsibility to make sure your vote is registered correctly.  If you later change your mind you may vote again; only your last valid vote will count.  Anonymous votes will not be accepted. Votes mailed by WWW/HTML/CGI forms are considered anonymous votes. (The vote must be mailed directly from the voter to the votetaker.)  In cases where voting fraud is determined to have occurred, it is standard operating procedure to delete ALL votes submitted by the violator.  If you give anyone a copy of the CFV, it must be whole and unmodified. When in doubt, ask the votetaker.  Standard Guidelines for voting apply: no more than one vote per person, no more than one vote per account. If you attempt multiple votes or other vote fraud, all your votes may be canceled and your name published.  The complete vote list will be posted with the vote result, including how each person voted. Note that Usenet votes are not done by secret ballot.  There will then be a five-day period during which the published vote list may be corrected and any irregularities addressed. The requirements for group creation are 100 more YES votes than NO votes, and 2/3 of all counted votes being YES.  DISTRBUTION This CFV has been cross posted to: 	bionet.virology 	sci.med 	sci.med.diseaes.cancer 	sci.med.pathology 	sci.med.telemedicine 	talk.politics.medicine  And EMailed to: 	HEPV-L mailing list ([email protected])  From [email protected] Fri Aug 11 14:54:33 1995 Path: uunet!bounce-back From: [email protected] (Warren Lavallee) Newsgroups: news.announce.newgroups,news.groups,bionet.virology,sci.med,sci.med.diseases.cancer,sci.med.pathology,sci.med.telemedicine,talk.politics.medicine Subject: RESULT: sci.med.diseases.hepatitis passes 148:19 Followup-To: news.groups Date: 11 Aug 1995 18:54:26 -0000 Organization: Usenet Volunteer Votetakers Lines: 265 Sender: [email protected] Approved: [email protected] Message-ID: <[email protected]> NNTP-Posting-Host: rodan.uu.net Archive-Name: sci.med.diseases.hepatitis Xref: uunet news.announce.newgroups:7328 news.groups:163884 bionet.virology:4148 sci.med:139080 sci.med.diseases.cancer:3939 sci.med.pathology:1170 sci.med.telemedicine:6608 talk.politics.medicine:31698                                  RESULT       unmoderated group sci.med.diseases.hepatitis passes 148:19  There were 148 YES votes and 19 NO votes, for a total of 167 valid votes. There were 3 abstains and 5 invalid ballots.  For group passage, YES votes must be at least 2/3 of all valid (YES and NO) votes.   There also must be at least 100 more YES votes than NO votes.  There is a five day discussion period after these results are posted.  If no serious allegations of voting irregularities are raised, the moderator of news.announce.newgroups will create the group shortly thereafter.    sci.med.diseases.hepatitis passed on Mon Jul 31 23:17:57 1995  Newsgroups line: sci.med.diseases.hepatitis	hepatitis diseases.  This vote was being conducted by a neutral third party. For voting questions only contact Warren Lavallee <[email protected]>. For questions about the proposed group contact Abdul W Abdul <[email protected]>.  RATIONALE  Hepatitis disease meaning the inflammation of the liver (hepat=liver, itis=inflammation) is a serious caused usually by hepatitis virus with millions of people infected throughout the world. The discussion of hepatitis diseases appears regularly in other related newsgroups such as sci.med, sci.med.diseases.cancer and bionet.virology, with demands for more information on the disease or even requests for help on particular issues conerning hepatitis. There is a mailing list for hepatitis C patients, and it is increasing daily in size. The mailing list members (more than 150) are interested in such newsgroup, because it will be there gateway to the world for getting more support and information.  I also found many supporters for the creation of this newsgroup, when I had posted a pre-RFD enquiry to bionet.virology.  CHARTER: sci.med.diseases.hepatitis  The proposed newsgroup would be devoted to all aspects and kinds of hepatitis diseases. This newsgroup would be a good place where all people interested in the disease (doctors and experts in this field) can communicate with each other and share views and opinions. Not forgetting millions of people who are infected with hepatitis, this newsgroup would give support to those people and would be a good place for them to interact with the experts. Let me make it clear here that the creation of this newsgroup is not intended to fractionate or separate hepatitis discussion in any other related newsgroup, but is to create a new specialized discussion forum on hepatitis diseases. So, articles regarding hepatitis cross-posted to other related newsgroups are welcomed.  A partial list of the intended topics would be:  	-All types of viral hepatitis and non viral hepatitis. 	-Prognosis and symptoms of hepatitis. 	-Complications of hepatitis. 	-The chronic carrier state. 	-Vaccines and drugs. 	-Epidemiology of hepatitis. 	-Books, journals, articles and newsletters related to hepatitis. 	-Support for hepatitis patients.  There is a plan to establish a gateway between HEPV-L mailing list and the newsgroup.  [This collection of addresses is (C)1995 by Consultix Computer Services. Permission is strictly NOT given to use this list or any part thereof to make a mailing list, or for mass-mailings.  Any other use is fine.] sci.med.diseases.hepatitis Final Vote Ack  Voted Yes ------------------------------------------------------------------------------ [email protected] [email protected]                                           Jonathan Adair [email protected]                                                   Andrew Hall [email protected]                                                 Tina M. Wood [email protected]                                Alwahabi Albanna [email protected]                                                 Fabio Puglisi [email protected]                                    Michael M. Morbey [email protected]                                                  April Quist [email protected]                                          Sally Baldwin [email protected]                    Laird   [email protected] [email protected]                                                  Barry Kolk [email protected]                                                       Dave Morey [email protected] [email protected] [email protected]                                                 B.J. Herbison [email protected]                                         Binh Nguyen [email protected] [email protected] [email protected]                                                           bud [email protected]                                                         Ivy Smith [email protected]               Curtis "Chewbacca" Desjardins [email protected]                                        Camilla Cracchiolo [email protected]                                            Carolina Smith [email protected]                                                  Chicago [email protected] [email protected] [email protected]                                             Claude V. Lucas [email protected]                                         Chris Stamper [email protected] [email protected]                                              Michael Piatak [email protected]                                          david (d.c.) cromwell [email protected] DAVENPORT%[email protected]    Robertson Davenport  M. [email protected]                                                               D [email protected]                                                       Debra Gaw [email protected]                                             David Miessler [email protected]                                                 Dave Scherman [email protected] [email protected]                                         Duane T. Williams [email protected] [email protected]                                     Edward T. Clayson [email protected]                                      Edith Cracchiolo [email protected]                                               Ellen Quach [email protected]                                           emorelan [email protected]                                             Eric Niekrug [email protected]                                            Albrecht Ernst [email protected]                                           Bob Hume [email protected]                                            mr. fishhead [email protected]                                         Linda Williams [email protected]                                               Greg Alt [email protected]                                                 Gib Fulton [email protected]                                                  Gregory Shaw [email protected]                                                Geff Thorpe [email protected]               Immunobiology Research Institute, Siena [email protected]                                    Ingrid Hellmer [email protected] [email protected] [email protected]                                                  Hop Hopingardner [email protected]                                           Henning Sauer [email protected]                                           Iain Pybus [email protected]                                     Elli R. Maguhn [email protected]                                                  Patrick J. O'Hara [email protected] [email protected] [email protected]                                                  jasper [email protected]                                             James M. Byers [email protected]                                                  Joanne Cook [email protected]                                     J.D. Almand [email protected]                                                    John Coates [email protected]                 Jean-Pierre Vanderwaeren [email protected]                                                 John F Walsh [email protected]                                               John Lowery [email protected]                                     Dr. John M. Taylor [email protected]                                          Joan Masters [email protected]                                     Joan Falciano [email protected]                                             hilgenberg [email protected]                                            Jon Eiseman [88] [email protected]                                                           Jonboy [email protected]                                        Sudish Joseph [email protected]                                                    Pat LeCourt [email protected]                                           Kristin King [email protected] [email protected]                                            Kenneth Hadlock [email protected]                                                  Lance K. Chun [email protected] [email protected]                                                  Larry [email protected]                                               Martin E. Lewitt [email protected]                                  Martin Schr"oder [email protected]                                             Lisa L Rosenblum [email protected]                                      loretta jacobs [email protected] [email protected]                                  Michael Jennings [email protected] [email protected] [email protected] [email protected]                                       Dr Michael Diffin [email protected]                                              MELVA J COOK [email protected]                                       Mark v.C. de Groot [email protected]                          Barry Mellovitz 4MG 7-2707 [email protected]                                             Michael Betel [email protected]                                                            Mimi [email protected]                                                  Mudplant [email protected] [email protected] [email protected]                                             Linda Palund [email protected]                                          Michael Ricci [email protected]                                             William Moxley [email protected]                                    Michelle Murrain [email protected]                                Nannette Simpson [email protected]                                                     Nigel Allen [email protected]                                   Frank Neipel [email protected]          Robert van den Nieuwendijk, tel. 08370-76750 [email protected]                                     Ollivier Robert [email protected]                                              Pat Fauquet [email protected] [email protected]    Understanding is a joy -- Tung Pham, DTN: 225-4938, [email protected]                                            United Initiatives [email protected]                                                     Paulo Melo [email protected]                                           Price Charles [email protected]                                          Len Moaven [email protected]                                             R.S.LITTLE [email protected]                                    Kristina Reiss [email protected]                                              Ed Douglas [email protected]                                     Rjurik Golobjatnikov [email protected]                                             Richard H. Miller [email protected]                                           Jeffrey Rufinus [email protected]                                                  Rhys Owen [email protected]                                                   Sara Amber [email protected]                                Pier L. San Biagio [email protected]                                  S. Churchvara [email protected]                                                 Gottesman [email protected]                                              Stuart F. Baldwin [email protected]                                    SHEARER, Ian [email protected] [email protected]                                            Sally A. Huber [email protected]                                                   Roy Starrin [email protected] [email protected]                                 Stuart Millinship [email protected]                                                   sueking [email protected] [email protected] [email protected]                                                    Tim Naylor [email protected] [email protected]                                               Tabor J. Wells [email protected]                                   Charles B. Wordell [email protected]                                  Lorna McCormick [email protected] [email protected]                                              Sam Kranzthor  Voted No ------------------------------------------------------------------------------ [email protected]                                               Michiel Wijers [email protected] [email protected]                                   Peter Scott Evans [email protected]                                                Dave Griles [email protected]                                     John M. Grohol [email protected]                                             HELGE HAUGLAND [email protected]                                                     HiTech [email protected]                                 Jeff Murphy [email protected]                                     John R. MacWilliamson [email protected]                                                Lon Jones [email protected]                                             Giovanni Maga [email protected]                                             Michael mink [email protected]                                               Dr A.J. Cann [email protected]                                               R S Rodgers [email protected]                                       Richard Spaete [email protected]                                                  Dwight Brown [email protected] [email protected]                                        Wolfgang Schmid [email protected]                                         Risto Widenius  Abstained ------------------------------------------------------------------------------ [email protected]                              Kenneth P Crouch [email protected]                                       Taneli Huuskonen [email protected]                                          M Mike Taksar KC6ZPS   Votes in error ------------------------------------------------------------------------------ [email protected]                                          Allen Shechtman    ! No vote statement in message [email protected]                                              Dorit Tavori    ! No vote statement in message [email protected]    ! No vote statement in message [email protected]    ! Invalid address [email protected]                                                        Statewd    ! No vote statement in message 
 
USENET FACT: Kill File
A set of filters setup to determine which user’s posts will be read/downloaded or ignored.
 
Menu